Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis

The variable phenotype and low-risk nature of RAS-positive thyroid nodules

(2015) Marco Medici et al.   BMC Medicine

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

(2014) Nishant Agrawal et al.   CELL

GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer

(2014) Fernand Labrie   ENDOCRINE-RELATED CANCER

DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival

(2014) Veronika Mancikova et al.   INTERNATIONAL JOURNAL OF CANCER

DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid Leukemia

(2014) Raajit Rampal et al.   Cell Reports

DNA Methylation Signatures Identify Biologically Distinct Thyroid Cancer Subtypes

(2013) Sandra Rodríguez-Rodero et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genome-Wide Methylation Patterns in Papillary Thyroid Cancer Are Distinct Based on Histological Subtype and Tumor Genotype

(2013) Ryan J. Ellis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells

(2011) Peng Hou et al.   ENDOCRINE-RELATED CANCER

Association ofPTENgene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors

(2008) Peng Hou et al.   CANCER